2370 Medinet
- 38
- -1-2.56%
Medinet News
Medinet: Financial results briefing materials for the fiscal year ending 2024/9
rakuten group, 3Q operating loss narrowing to ¥51 billion.
The earnings report for the third quarter of the fiscal year ending December 2024, announced by rakuten Group (4755), showed a revenue of 1 trillion 617.6 billion 21 million yen, an increase of 8.5% compared to the same period last year, while the operating loss was 51 billion 66 million yen (compared to a loss of 179.5 billion 78 million yen in the same period last year). Continued losses were burdensome due to upfront investments in the mobile business. The internet sector, including e-commerce (EC), and financial services were robust. [Positive evaluation] (7911) TOPPAN HD Mid-term| (3496) Azoom.
Medinet: Summary of financial results for the fiscal year ending September 2024 [Japanese GAAP] (unconsolidated)
Medinet Co Sees Parent FY Loss Y1.49B
Volume change rate ranking (9:00) - Bandai Namco, Ine, etc. ranked in.
In the volume change rate ranking, you can understand the market participants' interest in trends such as speculation by comparing the average volume for the past 5 days with the volume on the day of delivery. Top volume change rates [As of 9:32 on October 24] (comparison with the average volume for the past 5 days) Stock code Stock name Volume 5-day average volume Volume change rate Stock price change rate ＜4933＞Ine137400107185.08 154.44% 0.11% ＜1514＞Sumiishi
Volume change rate ranking (9:00) - Shima Chemical, Ribomic, etc. are ranked.
*In the volume change rate ranking, you can understand the interest of market participants such as trends in hunting by comparing the average volume of the past 5 days with the volume on the day of delivery.
The TOPIX Growth Market 250 Index fell for the third consecutive day, with the sudden drop in GENDA also affecting investor sentiment negatively.
Tokyo Stock Exchange Growth Market Index 808.04 -23.28 / Volume 0.2 billion 17.54 million shares / Trading value 116.6 billion yen Tokyo Stock Exchange Growth Market 250 Index 632.14 -18.68 / Volume 0.1 billion 57.87 million shares / Trading value 91.8 billion yen The growth market today, both the Tokyo Stock Exchange Growth Market Index and the Tokyo Stock Exchange Growth Market 250 Index fell for the first time in three days. The number of advancing stocks was 81, the number of declining stocks was 480, and unchanged was 21. The US market on the 10th was mixed. The Dow average is 92.63 dollars.
Emerging markets stock digest: Edge Technology significantly extended for the 5th consecutive day, ProdiLight hit the daily limit.
It has hit the daily limit and updated its year-to-date high. It was disclosed on the 9th that it obtained a patent related to technology that can analyze human emotions from voice, and it continues to be seen as a buying factor.
Volume change rate ranking (13:00) - Kaioom, Liberta, etc. are ranked
In the volume change rate ranking, you can know the market participants' interest in trends and other things by comparing the average volume of the past 5 days with the volume on the day of delivery. Top volume change rate [as of September 11, 13:32] (comparison of average volume of the past 5 days) Code ⇒ Stock name ⇒ Volume ⇒ 5-day average volume ⇒ Volume change rate ⇒ Stock price change rate <2370> MDNT 32429100 49370.52 343.59% 0.159% <3903>
MDNT - significant increase, strategic partnership agreement with AGC in the cell therapy drug CDMO business.
AGC <5201> announced that it has entered into a strategic partnership agreement in the cell therapy drug CDMO (contract manufacturing and development of pharmaceuticals and other products) business. The two companies will work on the exchange and development of human resources related to manufacturing and quality, and complement Medinet's development and manufacturing capabilities at AGC's domestic and overseas locations. First, AGC will accumulate knowledge and experience in Japan through Medinet's support, and prepare for the launch of cell therapy drug CDMO services at its Yokohama facility.
The TOPIX 250 index of the Tokyo Stock Exchange rose for the third consecutive day, with strong demand for major stocks.
TOPIX Growth Market Index 812.45 +26.10 / volumne 0.2 billion 38.78 million shares / trading value 128.1 billion yen. TOPIX Growth Market 250 Index 634.78 +22.75 / volume 0.1 billion 64.43 million shares / trading value 97.7 billion yen. Today's growth market, the TOPIX Growth Market Index rose for the 10th consecutive day, and the TOPIX Growth Market 250 Index rose for the 3rd consecutive day. The number of rising stocks was 464, falling stocks were 93, unchanged stocks were 30. The US stock market continued to rise on the 19th. The Dow Jones Industrial Average was up 236.77 points.
Volume change rate ranking (9am) - RepliCel, Fujifilm Pharmaceuticals, etc. ranked in.
In the volume change rate ranking, by comparing the volume of the last 5 days with the volume on the delivery day, market participants can understand the trend of the market's interest. Top volume change rate [as of August 19, 9:32am] (compared to the average volume of the last 5 days): stock code, stock name, volume, 5-day average volume, volume change rate, and stock price change rate. <2389> Digital HD, 377200, 107185.08, 241.5%, 0% <488>
MDNT - Recognition of non-operating income
On the 9th, Medinet <2370> announced the recording of non-operating income for the cumulative period of the third quarter of the fiscal year 2024 (October 1, 2023 to June 30, 2024). In the cumulative period of the second quarter (October 1, 2023 to March 31, 2024), the investment business association achieved good results, and a profit of 0.02 billion yen was recorded from the investment business association, and 0.14 billion yen is expected to be recorded during the third quarter accounting period (April 1, 2024 to June 30, 2024).
Medinet has started manufacturing a new specific cell processed product called "S-DSC(R)" for hair regeneration.
On the 8th, Medinet announced that it will begin manufacturing specific cell processed products used in the treatment of male and female hair loss using cultured autologous hair follicle dermal sheath cells (DSC) outsourcing. This treatment involves taking DSC cells from the scalp of the occipital area that has not experienced hair loss, amplifying these cells in vitro, and administering the resulting specific cell processed product (S-DSC(R)) to the hair loss area. In recent years, research for hair regeneration for the purpose of treating hair loss has been progressing, but it takes time for hair to grow.
Medinet-- 3Q also had double-digit revenue growth, and cell processing sales revenue is progressing smoothly.
Medinet <2370> announced its third quarter results for the fiscal year ending September 2024 (October 2023-June 2024) on the 9th. Revenue increased by 19.8% YoY to ¥0.589 billion, operating loss was ¥0.996 billion (compared to a loss of ¥1.046 billion in the same period last year), ordinary loss was ¥0.948 billion (compared to a loss of ¥1.043 billion in the same period last year), and net loss for the quarter was ¥0.951 billion (compared to a loss of ¥1.045 billion in the same period last year). Sales of the cell processing industry increased by 19.9% YoY to ¥0.589 billion, driven by the expansion of cell processing outsourcing.
MEDINET Co. Sees Sales Rise Amidst Losses
Emerging Market Stock Digest: Covered dropped sharply, NexTone hit the daily limit.
<5253> Cover 1527 fell sharply by -210. After the end of trading on the 8th, the performance of the 1st quarter of the 2025 fiscal year was announced, and selling pressure has become dominant. Revenue was ¥6.416 billion (an increase of 24.8% compared to the same period last year), and operating profit was ¥0.834 billion (a decrease of 6.8%). While the delivery/content sector is performing well, it seems that it did not meet investors' expectations. The company has made progress in improving the overall profitability of its business, but at the same time, it is concurrently expanding its content production capabilities and revenue department.
Medinet: Third quarter financial report for the September 2024 period (Japanese standard) (non-consolidated)
Hot stocks digest (morning session): Toshiba Electronic Devices & Storage Corporation, Institute for Immunology and Genetics, MDNT, etc.
H-One<5989> is showing buying interest at the limit up of 926 yen. The company announced its first quarter results the day before, with operating profit turning from a loss of 0.26 billion yen in the same period last year to a profit of 4.21 billion yen. The progress rate for the full-year plan of 11 billion yen remains at 38%, leading to a positive impact. The North American segment's sales grew, and revenue was pushed up by appropriate pricing and the depreciation of the yen. There was also a reduction in manufacturing costs such as labor expenses and a decrease in amortization burden, leading to increased earnings.
Volume change rate ranking (9 o'clock) - Arent, Takashima and others are ranked.
In the volume change rate ranking, you can understand the interest of market participants in the trend of the selection and other factors by comparing the average volume of the past five days with the volume on the day of delivery. In the top volume change rate [as of 9:33 am, August 9th] (compared with the average volume of the past five days), stock code stock name volume average volume of the past 5 days volume change rate stock price change rate <6855> electronic materials 857700 107,185.08 149.61 % -0.015.
No Data